Scarica l'app Stockscreener
3.72
1.85%
-0.07
Precedente Chiudi:
$3.79
Aprire:
$3.76
Volume 24 ore:
193.34K
Relative Volume:
0.78
Capitalizzazione di mercato:
$199.53M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-1.8803
EPS:
-1.9784
Flusso di cassa netto:
-
1 W Prestazione:
-7.58%
1M Prestazione:
-12.26%
6M Prestazione:
-33.33%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$3.605
$3.895
Intervallo di 1 settimana:
$3.605
$4.30
Portata 52W:
$2.34
$8.79
Anteris Technologies Global Corp Stock (AVR) Company Profile
Nome
Anteris Technologies Global Corp
Settore
Industria
Telefono
651-493-0606
Indirizzo
860 BLUE GENTIAN ROAD, EAGAN
Confronta AVR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
3.72 | 199.53M | 0 | 0 | 0 | -1.9784 |
|
ISRG
Intuitive Surgical Inc
|
537.99 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
177.67 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.02 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.26 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
222.42 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-08 | Iniziato | Lake Street | Buy |
| 2025-01-07 | Iniziato | Barclays | Overweight |
| 2025-01-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-01-07 | Iniziato | TD Cowen | Buy |
Anteris Technologies Global Corp Borsa (AVR) Ultime notizie
Anteris Technologies Global (ASX:AVR shareholders incur further losses as stock declines 15% this week, taking three-year losses to 72% - simplywall.st
Anteris Technologies Global (ASX:AVR) investors are sitting on a loss of 66% if they invested three years ago - Yahoo
FY2026 Earnings Forecast for AVR Issued By Cantor Fitzgerald - Defense World
Anteris Technologies Strengthens Board with Key Appointments - MSN
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - GlobeNewswire
Anteris Technologies Announces Director Departure - TipRanks
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - GlobeNewswire Inc.
Kalkine: Leadership Reshuffle at Anteris (ASX:AVR) Highlights Strategic Growth Amid ASX200 Momentum - Kalkine Media
anteris technologies appoints new board members and announces resignation By Investing.com - Investing.com South Africa
Anteris Technologies Appoints New Board Members - TipRanks
anteris technologies appoints new board members and announces resignation - Investing.com
Anteris Technologies Expands CDI Issuance in Strategic Securities Adjustment - TipRanks
Anteris Technologies Announces Cessation of Securities - TipRanks
Analyzing MSA Safety (NYSE:MSA) & Anteris Technologies Global (NASDAQ:AVR) - Defense World
Anteris Technologies Global Corp’s Lock-Up Period Set To End on June 11th (NASDAQ:AVR) - Defense World
Millennium Management LLC Purchases Shares of 313,298 Anteris Technologies Global Corp (NASDAQ:AVR) - Defense World
Will Anteris' DurAVR Spark A Paradigm Shift In The Transcatheter Aortic Valve Replacement Landscape? - RTTNews
Citadel Advisors LLC Makes New Investment in Anteris Technologies Global Corp (NASDAQ:AVR) - Defense World
Critical Survey: Anteris Technologies Global (NASDAQ:AVR) and Vicarious Surgical (NYSE:RBOT) - Defense World
Anteris Technologies advances toward PARADIGM trial after key regulatory and clinical milestones - Proactive financial news
Anteris Technologies Issues New Employee Incentive Securities - TipRanks
The morning catch up: ASX to extend gains as global optimism lifts markets - Proactive financial news
Anteris scales for pivotal PARADIGM Trial, plunging R&D investment into clinical activities - Proactive financial news
Anteris Technologies Advances Clinical Trial Efforts with DurAVR® THV - TipRanks
Anteris Technologies Reports Q1 2025 Results and Strategic Fund Allocation - TipRanks
Anteris Announces Results for the First Quarter of 2025 - The Manila Times
Earnings calendar for: - Yahoo
Modern-day gold prospectors in Stillwater are eying Wyoming, with plenty of investors backing them - Star Tribune
Anteris Technologies Files Amendment to Annual Report - TipRanks
Anteris Technologies Announces Cessation of Certain Securities - TipRanks
Anteris Technologies Global Corp. (AVR) Receives a Buy from Lake Street - The Globe and Mail
ASX Runners of the Week: Redstone Resources, Anteris & Jindalee Lithium - businessnews.com.au
Cantor Fitzgerald maintains Anteris stock Overweight with $9 target By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains Anteris stock Overweight with $9 target - Investing.com
Anteris Technologies Announces New Securities Quotation - TipRanks
NanoVibronix (NASDAQ:NAOV) & Anteris Technologies Global (NASDAQ:AVR) Head to Head Review - Defense World
Anteris Technologies Reports March 2025 CDI Adjustments - TipRanks
Anteris Technologies Marks Clinical Milestone with DurAVR® THV By Investing.com - Investing.com Canada
Anteris reports over 100 patients treated with new heart valve By Investing.com - Investing.com South Africa
Anteris Technologies Hits Milestone with DurAVR® Heart Valve Treatment - Zenopa
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV - GlobeNewswire
Anteris reports over 100 patients treated with new heart valve - Investing.com
Anteris Technologies announces 100 patients treated with DurAVR THV - TipRanks
Anteris Technologies Achieves Key Milestone in Cardiac Care - TipRanks
Anteris Technologies Global Corp Azioni (AVR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Anteris Technologies Global Corp Azioni (AVR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Paterson Wayne | Chief Executive Officer |
Mar 05 '25 |
Option Exercise |
7.13 |
233,000 |
1,661,290 |
233,000 |
| Denaro Stephen | Director |
Mar 11 '25 |
Option Exercise |
7.13 |
16,500 |
117,645 |
23,722 |
2.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):